![Samonnoi Sajani Banerjee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Samonnoi Sajani Banerjee
Founder at InfraScan, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Samit Satish Mehta | M | 44 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
Raj Mamodia | M | - |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA. | 10 years |
Namita Vikas Thapar | F | 47 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 years |
Berjis Minoo Desai | M | 67 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 27 years |
Satish Ramanlal Mehta | M | 73 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 43 years |
Baruch Ben-Dor | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | 20 years |
Palamadai S. Jayakumar | M | 62 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 4 years |
Sunil Rajanikant Mehta | M | 61 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 41 years |
Vidya Rajiv Yeravdekar | M | 60 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
Alan Wexler | M | 60 |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA. | 4 years |
Jennifer Harris | F | 58 |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA. | 2 years |
Robert E. Sell | M | 61 |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA. | 4 years |
Peter Chance | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | 20 years |
Vijay Gokhale | M | 65 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
Pavninder Singh | M | 47 |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA.
Bain Capital Advisors (India) Pvt Ltd.
| - |
Mukund Keshao Gurjar | M | 70 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 23 years |
Tajuddin Sabir Shaikh | M | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
Ashish Kotecha | M | 48 |
Bain Capital Advisors (India) Pvt Ltd.
| 14 years |
Saahil Bhatia | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 3 years |
Deepak Gondaliya | M | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 11 years |
Viren Rajani | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 2 years |
Abhiroop Jayanthi | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 6 years |
Arie Cohen | M | 76 |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | - |
aswin vikram | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 8 years |
Yosef Ben-Dor | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | - |
Vikas Thapar | M | 50 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 years |
Sanjay Rajanikant Mehta | M | 59 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 35 years |
Amit Ranbir Chandra | M | 54 |
Bain Capital Advisors (India) Pvt Ltd.
| 16 years |
Shahram Hejazi | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | - |
David L. Solt | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | - |
Shailesh Ayyangar | M | 69 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
Banu Onaral | M | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | 20 years |
Shiv Pathak | M | - |
Brillio LLC
![]() Brillio LLC Miscellaneous Commercial ServicesCommercial Services Brillio LLC provides consulting software services. It offers cloud transformation, intelligent enterprise, modern engineering, technology, design and consulting services. The company was founded by Raj Mamodia in 2014 and is headquartered in Santa Clara, CA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bashyam Renganathan | M | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 2 years |
Humayun Raja Dhanrajgir | M | 87 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
Hitesh Jain | M | 50 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
Fouad Benghalem | M | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
Pradeep Vaishnav | M | 67 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
Karen Stephens | F | - |
InfraScan, Inc.
![]() InfraScan, Inc. Medical SpecialtiesHealth Technology InfraScan, Inc. develops and distributes diagnostic imaging devices. It is a medical device company that invented and distributes hand-held diagnostic devices for head injury and stroke assessment based on Near-Infrared (NIR) technology. The Infrascanner enables clinicians to effectively, conveniently, and accurately detect intracranial bleeding in patients with head trauma. The company was founded by Baruch, Ben-Dor Baruch, Peter Chance, Sandeep Naik and Samonnoi Banerjee in 2004 and is headquartered in Philadelphia, PA. | - |
Sri Batchu | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 2 years |
Anirudh Jain | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 2 years |
Jayant Prakash | M | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 2 years |
Rishi Mandawat | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| - |
Yashraj Kaman | M | - | 2 years | |
Ankit Jajodia | M | - |
Bain Capital Advisors (India) Pvt Ltd.
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
India | 32 | 71.11% |
United States | 14 | 31.11% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Samonnoi Sajani Banerjee
- Personal Network